ACRS Quote, Trading Chart, Aclaris Therapeutics Inc.
home / stock / acrs / acrs quote
$17.08 Last:
-0.87% Change Percent:
$17.24 Open:
$17.08 Previous Close:
$17.5424 High:
$16.52 Low:
844,424 Volume:
06/24/2021 04:41:30 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
ACRS Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-24 | 17.24 | 17.08 | 17.5424 | 16.52 | 844,424 |
| 2021-06-23 | 18.1 | 17.23 | 18.21 | 17.19 | 687,101 |
| 2021-06-22 | 17.9 | 17.98 | 18.25 | 17.565 | 1,223,253 |
| 2021-06-21 | 18.27 | 17.91 | 18.3 | 17.66 | 491,749 |
| 2021-06-18 | 17.88 | 18.29 | 18.45 | 17.88 | 667,077 |
| 2021-06-17 | 17.77 | 18.16 | 18.61 | 17.77 | 651,678 |
| 2021-06-16 | 18.32 | 17.99 | 18.69 | 17.34 | 695,501 |
| 2021-06-15 | 18.5 | 17.81 | 18.5 | 17.37 | 972,163 |
| 2021-06-14 | 18.66 | 17.83 | 18.89 | 17.6 | 700,855 |
| 2021-06-11 | 19.51 | 18.38 | 19.74 | 18.17 | 955,264 |
| 2021-06-10 | 18.47 | 19.65 | 19.85 | 17.79 | 3,251,824 |
| 2021-06-09 | 18.11 | 17.765 | 18.63 | 16.82 | 1,638,111 |
| 2021-06-08 | 23.5 | 18.76 | 24 | 18.42 | 2,395,185 |
| 2021-06-07 | 21.65 | 22.38 | 23.2 | 21.0451 | 468,915 |
| 2021-06-04 | 21.98 | 21.73 | 22.6599 | 21.51 | 252,880 |
| 2021-06-03 | 21.78 | 21.9 | 22.5 | 21.51 | 535,985 |
| 2021-06-02 | 23.65 | 21.74 | 23.83 | 21 | 1,031,739 |
| 2021-06-01 | 22.29 | 23.64 | 23.81 | 22.25 | 480,334 |
| 2021-05-31 | 21.55 | 22.24 | 22.37 | 21.55 | 316,549 |
| 2021-05-28 | 21.55 | 22.24 | 22.37 | 21.55 | 316,549 |
Aclaris Therapeutics Inc. Company Name:
ACRS Stock Symbol:
NASDAQ Market:
Aclaris Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
ATI-1777 Achieved Statistically Significant Result in the Primary Efficacy Endpoint at Week 4 Minimal Systemic Exposure Supports “Soft” Topical JAK Inhibitor Approach ATI-1777 was Generally Well Tolerated Data Support Progression to Ph...
-
WAYNE, Pa., May 17, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, President and CEO of Aclaris, will present a...
-
Millions of people all over the world deal with arthritic pain. In fact, just in the U.S., the Centers for Disease Control and Prevention (CDC), says about 23% of adults are dealing with it. Nearly 24 million are limited with their activities because of it, with about 25% of people reportin...